| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| praziquantel | Tablet, film coated | 600 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 1/06/2024 |
| chlorhexidine gluconate | Solution, irrigation | 30 mg | Anticipated | Available | Manufacturing | 31/05/2024 |
| atropine sulfate monohydrate | Injection, solution | 1.2 mg/mL | Anticipated | Available | Manufacturing | 31/05/2024 |
| zolpidem tartrate | Tablet, film coated | 10 mg | Current | Limited Availability | Manufacturing | 31/05/2024 |
| bupivacaine hydrochloride~adrenaline (epinephrine) acid tartrate | Injection, solution | 2.5 mg/mL~4.5 microgram/mL | Current | Limited Availability | Manufacturing | 31/05/2024 |
| ceftazidime pentahydrate | Injection, powder for | 1.164 g | Current | Unavailable | Manufacturing | 31/05/2024 |
| midazolam | Injection, solution | 5 mg | Current | Limited Availability | Manufacturing | 31/05/2024 |
| remifentanil hydrochloride | Injection, powder for | 1.097 mg | Current | Unavailable | Manufacturing | 31/05/2024 |
| hydrocortisone sodium succinate | Injection, powder for | 334.25 mg | Resolved | Available | Manufacturing | 31/05/2024 |
| perindopril erbumine | Tablet | 8 mg | Current | Limited Availability | Manufacturing | 31/05/2024 |
| ropivacaine hydrochloride | Injection, solution | 7.5 mg/mL | Current | Unavailable | Manufacturing | 31/05/2024 |
| duloxetine hydrochloride | Capsule, enteric | 33.65 mg | Current | Unavailable | Manufacturing | 31/05/2024 |
| duloxetine hydrochloride | Capsule, enteric | 67.3 mg | Current | Unavailable | Manufacturing | 31/05/2024 |
| Abatacept | Injection | 125.875 mg | Current | Limited Availability | Unexpected increase in consumer demand | 31/05/2024 |
| esomeprazole magnesium dihydrate | Tablet, enteric coated | 43.5 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 31/05/2024 |
| cisatracurium besilate | Injection, solution | 201 mg | Current | Unavailable | Manufacturing | 31/05/2024 |
| Abatacept | Injection | 125.875 mg | Current | Limited Availability | Manufacturing | 31/05/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 31/05/2024 |
| tenofovir disoproxil maleate~emtricitabine | Tablet, film coated | 300 mg~200 mg | Current | Limited Availability | Manufacturing | 31/05/2024 |
| fluoxetine hydrochloride | Capsule, hard | 22.35 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 31/05/2024 |
| cinacalcet hydrochloride | Tablet | 33.064 mg | Current | Unavailable | Manufacturing | 31/05/2024 |
| cinacalcet hydrochloride | Tablet | 66.127 mg | Current | Unavailable | Manufacturing | 31/05/2024 |
| dosulepin (dothiepin) hydrochloride | Capsule, hard | 25 mg | Current | Limited Availability | Manufacturing | 31/05/2024 |
| sodium chloride | Injection, solution | 90 mg | Anticipated | Available | Manufacturing | 31/05/2024 |
| anastrozole | Tablet, film coated | 1 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 31/05/2024 |
| azithromycin dihydrate | Suspension, powder for | 209.65 mg | Current | Limited Availability | Unexpected increase in consumer demand | 31/05/2024 |
| albendazole | Tablet, chewable | 400 mg | Current | Unavailable | Commercial Changes / Commercial viability | 31/05/2024 |
| prazosin hydrochloride | Tablet, uncoated | 5.476 mg | Resolved | Available | Manufacturing | 30/05/2024 |
| calcium folinate | Injection | 324.1 mg | Anticipated | Available | Manufacturing | 30/05/2024 |
| adrenaline (epinephrine) acid tartrate~lidocaine hydrochloride monohydrate | Injection, solution | 22.7 microgram/mL~21.3 mg/mL | Anticipated | Available | Manufacturing | 30/05/2024 |
| ondansetron hydrochloride dihydrate | Injection, solution | 5 mg | Current | Limited Availability | Manufacturing | 30/05/2024 |
| propranolol hydrochloride | Tablet, film coated | 40 mg | Current | Limited Availability | Manufacturing | 30/05/2024 |
| atorvastatin calcium trihydrate~amlodipine besilate | Tablet, film coated | 86.751 mg~6.94 mg | Current | Limited Availability | Manufacturing | 30/05/2024 |
| tadalafil | Tablet, film coated | 5 mg | Anticipated | Available | Manufacturing | 30/05/2024 |
| rifampicin | Capsule | 150 mg | Resolved | Available | Manufacturing | 30/05/2024 |
| aciclovir sodium dihydrate | Injection, powder for | 314.4 mg | Anticipated | Available | Unexpected increase in consumer demand | 30/05/2024 |
| zopiclone | Tablet, film coated | 7.5 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 30/05/2024 |
| amikacin sulfate | Injection, solution | 333.76 mg/mL | Current | Unavailable | Manufacturing | 30/05/2024 |
| bupivacaine hydrochloride~adrenaline (epinephrine) acid tartrate | Injection, solution | 5 mg/mL~9.1 microgram/mL | Current | Unavailable | Manufacturing | 30/05/2024 |
| idarubicin hydrochloride | Injection, solution | 1 mg/mL | Current | Limited Availability | Manufacturing | 30/05/2024 |
| clonidine hydrochloride | Tablet, uncoated | 150 microgram | Current | Unavailable | Manufacturing | 30/05/2024 |
| mirtazapine | Tablet, film coated | 30 mg | Current | Unavailable | Manufacturing | 30/05/2024 |
| pravastatin sodium | Tablet, uncoated | 40 mg | Current | Limited Availability | Manufacturing | 30/05/2024 |
| clopidogrel hydrogen sulfate~aspirin | Tablet, film coated | 97.875 mg~100 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 29/05/2024 |
| ibuprofen~codeine phosphate hemihydrate | Tablet, film coated | 200 mg~12.8 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 29/05/2024 |
| levetiracetam | Tablet, film coated | 250 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 29/05/2024 |
| doxepin hydrochloride | Tablet, film coated | 56.5 mg | Resolved | Available | Manufacturing | 29/05/2024 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.76 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 29/05/2024 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Resolved | Available | Manufacturing | 29/05/2024 |
| zoledronic acid monohydrate | Injection, concentrated | .8528 mg/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 29/05/2024 |
| cefepime hydrochloride monohydrate | Injection, powder for | 2.378 g | Resolved | Available | Unexpected increase in consumer demand | 29/05/2024 |
| duloxetine hydrochloride | Capsule, enteric | 33.65 mg | Current | Limited Availability | Manufacturing | 29/05/2024 |
| pregabalin | Capsule, hard | 300 mg | Resolved | Available | Commercial Changes / Commercial viability | 29/05/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 29/05/2024 |
| ezetimibe | Tablet | 10 mg | Resolved | Available | Manufacturing | 29/05/2024 |
| tadalafil | Tablet, film coated | 5 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 29/05/2024 |
| atomoxetine hydrochloride | Capsule, hard | 45.5 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 29/05/2024 |
| lacosamide | Tablet, film coated | 100 mg | Resolved | Available | Manufacturing | 29/05/2024 |
| rosuvastatin calcium | Tablet, film coated | 41.68 mg | Resolved | Available | Manufacturing | 29/05/2024 |
| mycophenolate sodium | Tablet, enteric coated | 384.8 mg | Resolved | Available | Manufacturing | 29/05/2024 |
| Teriparatide | Injection, solution | 250 microgram/mL | Anticipated | Available | Manufacturing | 29/05/2024 |
| melphalan | Injection, powder for | 50 mg | Current | Unavailable | Manufacturing | 29/05/2024 |
| warfarin sodium | Tablet, uncoated | 5 mg | Current | Limited Availability | Manufacturing | 28/05/2024 |
| ciprofloxacin hydrochloride | Tablet, film coated | 832.5 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 28/05/2024 |
| ciprofloxacin~hydrocortisone | Ear Drops, suspension | 2 mg/mL~10 mg/mL | Current | Limited Availability | Manufacturing | 28/05/2024 |
| rocuronium bromide | Injection, solution | 50 mg | Resolved | Available | Manufacturing | 28/05/2024 |
| amlodipine besilate | Tablet | 13.87 mg | Current | Limited Availability | Manufacturing | 28/05/2024 |
| codeine phosphate hemihydrate~paracetamol~doxylamine succinate | Tablet, uncoated | 10 mg~500 mg~5.1 mg | Current | Unavailable | Manufacturing | 28/05/2024 |
| felypressin~prilocaine hydrochloride | Injection, solution | .54 microgram/mL~30 mg/mL | Anticipated | Available | Manufacturing | 28/05/2024 |
| voriconazole | Injection, powder for | 200 mg | Current | Unavailable | Commercial Changes / Commercial viability | 28/05/2024 |
| atorvastatin calcium trihydrate | Tablet, film coated | 10.845 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 28/05/2024 |
| nebivolol hydrochloride | Tablet | 5.45 mg | Current | Unavailable | Manufacturing | 28/05/2024 |
| lacosamide | Tablet, film coated | 100 mg | Current | Limited Availability | Manufacturing | 28/05/2024 |
| cisplatin | Injection, solution | 1 mg/mL | Resolved | Available | Manufacturing | 28/05/2024 |
| heparin sodium | Injection, solution | 1000 IU/mL | Current | Unavailable | Manufacturing | 28/05/2024 |
| felodipine~ramipril | Tablet, modified release | 2.5 mg~2.5 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 28/05/2024 |
| epoprostenol sodium | Injection, powder for | .531 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 28/05/2024 |
| epoprostenol sodium | Injection, powder for | 1.593 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 28/05/2024 |
| trandolapril | Capsule | 2 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 27/05/2024 |
| imatinib mesilate | Tablet, film coated | 119.5 mg | Resolved | Available | Manufacturing | 27/05/2024 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Anticipated | Available | Manufacturing | 27/05/2024 |
2024年6月10日